BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//ifos2026//PLSF3T
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-EWBEFG@sciencenext.org
DTSTART;TZID=EET:20260910T070000
DTEND;TZID=EET:20260910T073000
DESCRIPTION:<p style="margin-left: 0px!important\;">The use of CPAP was onc
 e contested due to low adherence and\, subsequently\, because studies fail
 ed to demonstrate real changes in the health of treated individuals\, even
  though it improved daytime sleepiness\, with no real impact on improving 
 comorbidities. This has been demystified by greater adherence with the use
  of the technology and new studies showing a positive impact on associated
  diseases.</p>
DTSTAMP:20260618T223055Z
LOCATION:Sleep
SUMMARY:CPAP treatment for OSA is improving adherence through the use of te
 chnology\, physician monitoring\, and a supportive team. - Clarissa Delpiz
 zo Castagno
URL:https://sciencenext.org/ifos2026/talk/EWBEFG/
END:VEVENT
BEGIN:VEVENT
UID:pretalx-ifos2026-X7E9RS@sciencenext.org
DTSTART;TZID=EET:20260910T073000
DTEND;TZID=EET:20260910T074500
DESCRIPTION:<p style="margin-left: 0px!important\;">From the data collected
  at a private clinic in southern Brazil\, I found data on CPAP adaptation 
 in approximately 100 patients (2021 / 2022)\, based on monitoring and adap
 tation in the clinic itself. We selected only one brand of equipment from 
 those available in Brazil. Of the patients selected for data monitoring\, 
 we obtained greater adherence compared to the data demonstrated in the lit
 erature. What are the factors that increase this adherence? Medical care a
 nd monitoring in the clinic itself can make all the difference. The object
 ive is to discuss the concern with the selection of CPAP treatment for OSA
 . </p>
DTSTAMP:20260618T223055Z
LOCATION:Sleep
SUMMARY:Adaptation to CPAP as a form of treatment for OSA\, in a private me
 dical practice - Clarissa Delpizzo Castagno
URL:https://sciencenext.org/ifos2026/talk/X7E9RS/
END:VEVENT
END:VCALENDAR